RU94035038A - Method for treating disseminated psoriasis - Google Patents

Method for treating disseminated psoriasis

Info

Publication number
RU94035038A
RU94035038A RU94035038/14A RU94035038A RU94035038A RU 94035038 A RU94035038 A RU 94035038A RU 94035038/14 A RU94035038/14 A RU 94035038/14A RU 94035038 A RU94035038 A RU 94035038A RU 94035038 A RU94035038 A RU 94035038A
Authority
RU
Russia
Prior art keywords
cryo
destruction
drug
treatment
psoriasis
Prior art date
Application number
RU94035038/14A
Other languages
Russian (ru)
Other versions
RU2090194C1 (en
Inventor
И.А. Скворцов
А.В. Карякин
Original Assignee
И.А. Скворцов
А.В. Карякин
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by И.А. Скворцов, А.В. Карякин filed Critical И.А. Скворцов
Priority to RU94035038A priority Critical patent/RU2090194C1/en
Publication of RU94035038A publication Critical patent/RU94035038A/en
Application granted granted Critical
Publication of RU2090194C1 publication Critical patent/RU2090194C1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

FIELD: medicine. SUBSTANCE: method involves performing cryo protection of hair follicles before doing cryo destruction. The cryo destruction is performed sector by sector with hemosorption performed between the cryo destruction sessions. EFFECT: prevented complications; accelerated treatment course.

Claims (1)

Изобретение относится к медицине, а именно к способам получения препаратов гидролизатов мозговой ткани. Технический результат: повышение эффективности лечения и сокращение сроков реабилитации у больных с нарушениями координации движений, достигается тем, что впервые разработан препарат для лечения координаторных нарушений из мозжечково-стволового отдела головного мозга. Введение гидролизатного препарата осуществляется параэнтерально микродозами в склеромерные паравентебральные зоны, соответствующие шейным и верхним грудным сегментам, и/или околоневральные зоны подъязычного нерва и магистральных стволов нервов верхних и нижних конечностей.The invention relates to medicine, namely to methods for producing preparations of brain tissue hydrolysates. Technical result: increasing the effectiveness of treatment and reducing the time of rehabilitation in patients with impaired coordination of movements, is achieved by the fact that for the first time a drug has been developed for the treatment of coordinating disorders from the cerebellar-stem part of the brain. The introduction of the hydrolyzate drug is carried out parenterally by microdoses in the scleromeric paraventerebral zones corresponding to the cervical and upper thoracic segments, and / or the peroneural zones of the hyoid nerve and main trunks of nerves of the upper and lower extremities.
RU94035038A 1994-09-30 1994-09-30 Method for producing preparation for treating coordination disturbances in cerebellum and brain stem region RU2090194C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU94035038A RU2090194C1 (en) 1994-09-30 1994-09-30 Method for producing preparation for treating coordination disturbances in cerebellum and brain stem region

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU94035038A RU2090194C1 (en) 1994-09-30 1994-09-30 Method for producing preparation for treating coordination disturbances in cerebellum and brain stem region

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU93003564A Division RU2063757C1 (en) 1993-01-21 1993-01-21 Method for treating coordination disorders

Publications (2)

Publication Number Publication Date
RU94035038A true RU94035038A (en) 1996-07-10
RU2090194C1 RU2090194C1 (en) 1997-09-20

Family

ID=20160663

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94035038A RU2090194C1 (en) 1994-09-30 1994-09-30 Method for producing preparation for treating coordination disturbances in cerebellum and brain stem region

Country Status (1)

Country Link
RU (1) RU2090194C1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2302871C1 (en) * 2006-06-22 2007-07-20 Общество С Ограниченной Ответственностью "Сиа Пептайдс" Brain functions normalizing agent and a method for preparation thereof
RU2445106C1 (en) * 2010-07-01 2012-03-20 Закрытое Акционерное Общество "Фарм-Синтез" Pharmaceutical composition for treating central and peripheral nervous system disorders of cardiovascular, traumatic, toxic, hypoxic and autoimmune genesis
RU2503457C2 (en) * 2012-03-22 2014-01-10 Федеральное государственное бюджетное учреждение "Научный центр биомедицинских технологий" Российской академии медицинских наук Agent for extreme performance stimulation
RU2669692C1 (en) * 2017-08-14 2018-10-15 Павел Андреевич Канаев Method for producing complex of biologically active peptides with neurotropic activity
RU2669691C1 (en) * 2017-08-14 2018-10-15 Павел Андреевич Канаев Method for producing a complex of biologically active peptides having immunostimulating activity

Also Published As

Publication number Publication date
RU2090194C1 (en) 1997-09-20

Similar Documents

Publication Publication Date Title
GEP20002146B (en) Therapeutic Peptide Derivatives
DE69428268D1 (en) USE OF LOCALANE ESTHETIC FOR PRODUCING A MEDICINAL PRODUCT FOR TREATING BRONCHIAL AESTHMA
RU94027680A (en) Parathyroid hormone and raloxifen for bone mass increase, pharmaceutical composition and method of osseous mass increase
ATE258796T1 (en) USE OF VITAMIN D4 DERIVATIVES TO TREAT SKIN DISEASES
ATE213411T1 (en) USE OF PHENSERINE IN THE PRODUCTION OF MEDICATIONS FOR THE TREATMENT OF COGNITIVE DISORDERS
RU94035038A (en) Method for treating disseminated psoriasis
DE69821970D1 (en) Use of CITICOLINE FOR TREATING MULTIPLE Sclerosis
RU2038102C1 (en) Method for treating the cases of vibration disease
RU2198646C2 (en) Method for treating autonomic-sensory polyneuropathy
RU2122869C1 (en) Method of treating speech disturbances
RU94019363A (en) Method for restoring peripheral nerve conductivity in late posttraumatic period
GEP19981480B (en) Method for Treating Vertebral Column
RU2103977C1 (en) Method of treatment of joint osteoarthrosis
SU858826A1 (en) Method of galvanopuncture reflexotherapy
RU2086226C1 (en) Method for treating reflexogenic vascular syndromes accompanying osteochondroses
SU1044286A1 (en) Method of treating trigeminal nerve neuralgia
RU2137460C1 (en) Method for restoring mimic muscle function
RU95101233A (en) METHOD FOR TREATING NEUROSENSOR Hearing Aid
SU1745246A1 (en) Method for treatment of arthroses
RU94006635A (en) Method for correcting functional state
SU1745220A1 (en) Method for functional rehabilitation of the facial muscles after an injury to the facial nerve in patients with benign tumors of the parotid gland
EP0241462A1 (en) Hair treatment method
RU2088201C1 (en) Method for treating trifacial nerve neuralgia
Corssen Hypophyseal stimulation and the role of the pituitary inhibitory system (PIS) in the control of cancer pain
MD404C2 (en) Modulating aerionic stimulator